Vera Therapeutics, INC. (VERA) — 10-Q Filings

10-Q Filings (5)

• Vera Therapeutics' Losses Double Amid Soaring R&D Costs — Nov 5, 2025 Risk: high
  Vera Therapeutics, Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $208.5 million, a substantial rise fr
• Vera Therapeutics' Net Loss Widens Amid Rising R&D Costs — Aug 5, 2025 Risk: high
  Vera Therapeutics, Inc. reported a net loss of $49.7 million for the three months ended June 30, 2025, an increase from a net loss of $40.1 million for the same
• Vera Therapeutics Files Q1 2025 10-Q — May 7, 2025 Risk: medium
  Vera Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position, including cash and equivalents, and de
• Vera Therapeutics Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  Vera Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its business
• Vera Therapeutics Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: medium
  Vera Therapeutics, Inc. (VERA) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Vera Therapeutics, Inc. filed a 10-Q report for the period ending M

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX